Medacta Group Statistics

Total Valuation

Medacta Group has a market cap or net worth of GBP 2.39 billion. The enterprise value is 2.57 billion.

Market Cap	2.39B
Enterprise Value	2.57B

Important Dates

The next estimated earnings date is Monday, September 8, 2025.

Earnings Date	Sep 8, 2025
Ex-Dividend Date	May 9, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.18%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.99M

Valuation Ratios

The trailing PE ratio is 39.59.

PE Ratio	39.59
Forward PE	n/a
PS Ratio	4.89
PB Ratio	7.60
P/TBV Ratio	7.87
P/FCF Ratio	161.38
P/OCF Ratio	26.93
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.13, with an EV/FCF ratio of 173.58.

EV / Earnings	42.58
EV / Sales	5.11
EV / EBITDA	20.13
EV / EBIT	32.49
EV / FCF	173.58

Financial Position

The company has a current ratio of 2.51, with a Debt / Equity ratio of 0.64.

Current Ratio	2.51
Quick Ratio	0.95
Debt / Equity	0.64
Debt / EBITDA	1.63
Debt / FCF	13.64
Interest Coverage	12.37

Financial Efficiency

Return on equity (ROE) is 20.54% and return on invested capital (ROIC) is 10.04%.

Return on Equity (ROE)	20.54%
Return on Assets (ROA)	7.81%
Return on Invested Capital (ROIC)	10.04%
Return on Capital Employed (ROCE)	14.64%
Revenue Per Employee	256,105
Profits Per Employee	31,607
Employee Count	1,907
Asset Turnover	0.79
Inventory Turnover	0.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +18.99% in the last 52 weeks. The beta is 1.19, so Medacta Group's price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+18.99%
50-Day Moving Average	128.11
200-Day Moving Average	121.51
Relative Strength Index (RSI)	60.99
Average Volume (20 Days)	2,285

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medacta Group had revenue of GBP 488.39 million and earned 60.27 million in profits. Earnings per share was 3.02.

Revenue	488.39M
Gross Profit	330.32M
Operating Income	76.86M
Pretax Income	72.58M
Net Income	60.27M
EBITDA	117.59M
EBIT	76.86M
Earnings Per Share (EPS)	3.02

Full Income Statement

Balance Sheet

The company has 26.12 million in cash and 201.68 million in debt, giving a net cash position of -175.55 million.

Cash & Cash Equivalents	26.12M
Total Debt	201.68M
Net Cash	-175.55M
Net Cash Per Share	n/a
Equity (Book Value)	313.97M
Book Value Per Share	15.76
Working Capital	196.68M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 88.60 million and capital expenditures -73.82 million, giving a free cash flow of 14.79 million.

Operating Cash Flow	88.60M
Capital Expenditures	-73.82M
Free Cash Flow	14.79M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 67.64%, with operating and profit margins of 15.74% and 12.34%.

Gross Margin	67.64%
Operating Margin	15.74%
Pretax Margin	14.86%
Profit Margin	12.34%
EBITDA Margin	24.08%
EBIT Margin	15.74%
FCF Margin	3.03%

Dividends & Yields

This stock pays an annual dividend of 0.48, which amounts to a dividend yield of 0.37%.

Dividend Per Share	0.48
Dividend Yield	0.37%
Dividend Growth (YoY)	-0.08%
Years of Dividend Growth	n/a
Payout Ratio	15.36%
Buyback Yield	0.18%
Shareholder Yield	0.55%
Earnings Yield	2.53%
FCF Yield	0.62%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medacta Group has an Altman Z-Score of 5.8.

Altman Z-Score	5.8
Piotroski F-Score	n/a